Terms: = Colorectal cancer AND DDX5, HLR1, 1655, ENSG00000108654, P17844, DKFZp686J01190, p68, G17P1, HUMP68
38 results:
1. Comprehensive Proteogenomic Profiling Reveals the Molecular Characteristics of colorectal cancer at Distinct Stages of Progression.
Li L; Jiang D; Liu H; Guo C; Zhang Q; Li X; Chen X; Chen Z; Feng J; Tan S; Huang W; Huang J; Xu C; Liu CY; Yu W; Hou Y; Ding C
Cancer Res; 2024 Sep; 84(17):2888-2910. PubMed ID: 38861363
[TBL] [Abstract] [Full Text] [Related]
2. [Incidence of postoperative complications in Chinese patients with gastric or colorectal cancer based on a national, multicenter, prospective, cohort study].
Zhang SQ; Wu ZQ; Huo BW; Xu HN; Zhao K; Jing CQ; Liu FL; Yu J; Li ZR; Zhang J; Zang L; Hao HK; Zheng CH; Li Y; Fan L; Huang H; Liang P; Wu B; Zhu JM; Niu ZJ; Zhu LH; Song W; You J; Yan S; Li ZY
Zhonghua Wei Chang Wai Ke Za Zhi; 2024 Mar; 27(3):247-260. PubMed ID: 38532587
[No Abstract] [Full Text] [Related]
3. ddx5 (p68) orchestrates β-catenin, RelA and SP1 mediated MGMT gene expression in human colon cancer cells: Implication in TMZ chemoresistance.
Shaw R; Karmakar S; Basu M; Ghosh MK
Biochim Biophys Acta Gene Regul Mech; 2023 Dec; 1866(4):194991. PubMed ID: 37793472
[TBL] [Abstract] [Full Text] [Related]
4. The DEAD-box RNA helicase ddx5 (p68) and β-catenin: The crucial regulators of FOXM1 gene expression in arbitrating colorectal cancer.
Tabassum S; Basu M; Ghosh MK
Biochim Biophys Acta Gene Regul Mech; 2023 Jun; 1866(2):194933. PubMed ID: 36997114
[TBL] [Abstract] [Full Text] [Related]
5. CSN6 Mediates Nucleotide Metabolism to Promote Tumor Development and Chemoresistance in colorectal cancer.
Zou S; Qin B; Yang Z; Wang W; Zhang J; Zhang Y; Meng M; Feng J; Xie Y; Fang L; Xiao L; Zhang P; Meng X; Choi HH; Wen W; Pan Q; Ghesquière B; Lan P; Lee MH; Fang L
Cancer Res; 2023 Feb; 83(3):414-427. PubMed ID: 36512632
[TBL] [Abstract] [Full Text] [Related]
6. colorectal cancer concurrent gene signature based on coherent patterns between genomic and transcriptional alterations.
Shen MH; Huang CJ; Ho TF; Liu CY; Shih YY; Huang CS; Huang CC
BMC Cancer; 2022 May; 22(1):590. PubMed ID: 35637462
[TBL] [Abstract] [Full Text] [Related]
7. FL118, acting as a 'molecular glue degrader', binds to dephosphorylates and degrades the oncoprotein ddx5 (p68) to control c-Myc, survivin and mutant Kras against colorectal and pancreatic cancer with high efficacy.
Ling X; Wu W; Aljahdali IAM; Liao J; Santha S; Fountzilas C; Boland PM; Li F
Clin Transl Med; 2022 May; 12(5):e881. PubMed ID: 35604033
[TBL] [Abstract] [Full Text] [Related]
8. A primary rectal neoplasm with novel ddx5-TFEB fusion.
Zhang M; Yin X; Chen J; Zhu S; Zheng L; Zeng H; Zhou Q; Chen N
Virchows Arch; 2022 Sep; 481(3):511-516. PubMed ID: 35397700
[TBL] [Abstract] [Full Text] [Related]
9. Insulin-like growth factor 2 mRNA-binding protein 2-stabilized long non-coding RNA Taurine up-regulated gene 1 (TUG1) promotes cisplatin-resistance of colorectal cancer via modulating autophagy.
Xia C; Li Q; Cheng X; Wu T; Gao P; Gu Y
Bioengineered; 2022 Feb; 13(2):2450-2469. PubMed ID: 35014946
[TBL] [Abstract] [Full Text] [Related]
10. Wnt/β-catenin signaling and p68 conjointly regulate CHIP in colorectal carcinoma.
Kal S; Chakraborty S; Karmakar S; Ghosh MK
Biochim Biophys Acta Mol Cell Res; 2022 Mar; 1869(3):119185. PubMed ID: 34890713
[TBL] [Abstract] [Full Text] [Related]
11. Circular RNA circEGFR regulates tumor progression via the miR-106a-5p/ddx5 axis in colorectal cancer.
Fu P; Lin L; Zhou H; Zhao S; Jie Z
Braz J Med Biol Res; 2021; 54(8):e10940. PubMed ID: 34320120
[TBL] [Abstract] [Full Text] [Related]
12. Long-term outcome and quality of life after continent ileostomy for ulcerative colitis: A systematic review.
Deputy M; Worley G; Patel K; Fletcher J; Hart A; Block M; Øresland T; Myrelid P; Faiz O
Colorectal Dis; 2021 Sep; 23(9):2286-2299. PubMed ID: 34166559
[TBL] [Abstract] [Full Text] [Related]
13. A nine-gene signature to improve prognosis prediction of colon carcinoma.
Zhao J; Wang Y; Gao J; Wang Y; Zhong X; Wu X; Li H
Cell Cycle; 2021 May; 20(10):1021-1032. PubMed ID: 33985413
[TBL] [Abstract] [Full Text] [Related]
14. LncRNA PRADX-mediated recruitment of PRC2/ddx5 complex suppresses UBXN1 expression and activates NF-κB activity, promoting tumorigenesis.
Li Y; Liu X; Cui X; Tan Y; Wang Q; Wang Y; Xu C; Fang C; Kang C
Theranostics; 2021; 11(9):4516-4530. PubMed ID: 33754075
[No Abstract] [Full Text] [Related]
15. WGCNA reveals key gene modules regulated by the combined treatment of colon cancer with PHY906 and CPT11.
Xing S; Wang Y; Hu K; Wang F; Sun T; Li Q
Biosci Rep; 2020 Sep; 40(9):. PubMed ID: 32812032
[TBL] [Abstract] [Full Text] [Related]
16. The Incidence of Low Anterior Resection Syndrome as Assessed in an International Randomized Controlled Trial (MRC/NIHR ROLARR).
Bolton WS; Chapman SJ; Corrigan N; Croft J; Collinson F; Brown JM; Jayne DG
Ann Surg; 2021 Dec; 274(6):e1223-e1229. PubMed ID: 32097165
[TBL] [Abstract] [Full Text] [Related]
17. RNA helicase p68 deploys β-catenin in regulating RelA/p65 gene expression: implications in colon cancer.
Khare V; Tabassum S; Chatterjee U; Chatterjee S; Ghosh MK
J Exp Clin Cancer Res; 2019 Jul; 38(1):330. PubMed ID: 31351496
[TBL] [Abstract] [Full Text] [Related]
18. O-GlcNAcylation promotes colorectal cancer progression by regulating protein stability and potential catcinogenic function of ddx5.
Wu N; Jiang M; Han Y; Liu H; Chu Y; Liu H; Cao J; Hou Q; Zhao Y; Xu B; Xie X
J Cell Mol Med; 2019 Feb; 23(2):1354-1362. PubMed ID: 30484950
[TBL] [Abstract] [Full Text] [Related]
19. The lncRNA NEAT1 activates Wnt/β-catenin signaling and promotes colorectal cancer progression via interacting with ddx5.
Zhang M; Weng W; Zhang Q; Wu Y; Ni S; Tan C; Xu M; Sun H; Liu C; Wei P; Du X
J Hematol Oncol; 2018 Sep; 11(1):113. PubMed ID: 30185232
[TBL] [Abstract] [Full Text] [Related]
20. The DEAD box protein p68: a novel coactivator of Stat3 in mediating oncogenesis.
Sarkar M; Khare V; Ghosh MK
Oncogene; 2017 Jun; 36(22):3080-3093. PubMed ID: 27941883
[TBL] [Abstract] [Full Text] [Related]
[Next]
